首页> 外文期刊>Veterinary Research Communications >Coexpression of 16.8 kDa antigen of Mycobacterium avium paratuberculosis and murine gamma interferon in a bicistronic vector and studies on its potential as DNA vaccine
【24h】

Coexpression of 16.8 kDa antigen of Mycobacterium avium paratuberculosis and murine gamma interferon in a bicistronic vector and studies on its potential as DNA vaccine

机译:在双顺反应载体中的三分之一的分枝杆菌抗菌菌和鼠γ干扰素的16.8kDa抗原的共表达及其作为DNA疫苗的潜力研究

获取原文
获取原文并翻译 | 示例
       

摘要

Paratuberculosis or Johne's disease is a chronic gastric disease of ruminants. For this disease there is no effective treatment or preventive measure available. 16.8 kDa protein is an immunogenic protein of Mycobacterium avium paratuberculosis and can be an ideal candidate for developing a DNA vaccine construct. In present study a bicistronic DNA vaccine construct pIR16.8/IFN was developed using eukaryotic vector pIRES 6.1. Two genes MPT (expressing 16.8 kDa protein) and murine IFNd were cloned, expressed and immunoreactivity was studied in murine model. Immunoreactivity was also compared with monocistronic construct pIR16.8 expressing 16.8 kDa protein. Both pIR16.8 and pIR16.8/IFN showed eukaryotic expression of respective proteins in BHK21 cells. The expressed proteins also showed immunoreactivity when reacted with hyperimmune sera raised against recombinant 16.8 kDa protein in western blot assay and immunofluorence assay. Both constructs were used as DNA vaccine in murine model and immunogenecity was studied by DTH, lymphocyte proliferation assay and NO determination. DTH reaction was significantly high in pIR16.8/IFN than pIR16.8 group, similarly lymphocyte proliferation and NO release was higher in pIR16.8/IFN group than pIR16.8 group. This indicated T cell epitopic nature of 16.8 kDa protein. The study also showed that co-expression of IFNd with mycobacterial gene can enhance immunogenecity of DNA vaccine and can be used as immunoadjuvant.
机译:副植物或约翰的疾病是反刍动物的慢性胃病。对于这种疾病,没有有效的治疗或预防措施可用。 16.8 kda蛋白是分枝杆菌的免疫原性蛋白质,可以是用于开发DNA疫苗构建体的理想候选者。在目前的研究中,使用真核载体PIRS 6.1开发了双顺函DNA疫苗构建PIR16.8 / IFN。克隆了两种基因MPT(表达16.8kDa蛋白)和鼠IFND,在鼠模型中研究了免疫反应性。还将免疫反应与表达16.8kDa蛋白的单锁相构建PiR16.8进行比较。 PiR16.8和PiR16.8 / IFN均显示在BHK21细胞中各自的蛋白质的真核表达。当表达的蛋白质也显示出与蛋白质印迹测定和免疫荧光测定中的重组16.8kDa蛋白升高的超显鼠血清反应时的免疫反应性。两种构建体都被用作鼠模型中的DNA疫苗,通过DTH,淋巴细胞增殖测定法研究免疫发作,没有测定。 PIR16.8 / IFN中的第三次反应显着高于PiR16.8组,同样的淋巴细胞增殖和PiR16.8 / IFN组没有释放比Piro16.8组。这表明T细胞表位性质为16.8kDa蛋白。该研究还表明,具有分枝杆菌基因的IFND的共同表达可以增强DNA疫苗的免疫原性,可用作免疫谐腾。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号